You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor recurrence

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma (GBM) Trial in Basel (Advanced diffusion-weighted MRI (ADW-MRI))

Recruiting
  • Glioblastoma (GBM)
  • Advanced diffusion-weighted MRI (ADW-MRI)
  • Basel, Switzerland
    University Hospital Basel
Jun 21, 2023

Tumor Recurrence Following Radiotherapy

Recruiting
  • Prostate Cancer
    • Rochester, Minnesota
      Mayo Clinic
    Jan 20, 2023

    Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing

    Not yet recruiting
    • Non-Muscle Invasive Bladder Cancer
    • +4 more
    • Behavioral: Motivational Interviewing with WhatsApp video call
    • Istanbul, Turkey
      İrem Nur Ozdemir
    Jan 20, 2023

    Liver Cancer, Tumor Recurrence, Hepatocellular Carcinoma Trial in Bologna (Hypothermic oxygenated Perfusion - HOPE)

    Not yet recruiting
    • Liver Cancer
    • +4 more
    • Hypothermic oxygenated Perfusion - HOPE
    • Bologna, Italy
      IRCCS Azienda Ospedaliero-Universitaria di Bologna
    May 16, 2023

    Tumor Recurrence After Abdominal-perineal Amputation in Squamous

    Active, not recruiting
    • Squamous Cell Carcinoma of the Anal Canal
      • Paris, France
        Groupe Hospitalier Paris Saint-Joseph
      Jun 29, 2022

      Solid Tumor Trial in Shanghai (DC cells)

      Recruiting
      • Solid Tumor
      • DC cells
      • Shanghai, Shanghai, China
        Shanghai Mengchao Cancer Hospital
      Aug 23, 2023

      Breast Cancer, Tumor, Breast Trial in Cleveland (Radiation Therapy)

      Not yet recruiting
      • Breast Cancer
      • Tumor, Breast
      • Radiation Therapy
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Seidman Cancer Ce
      Nov 13, 2023

      Postoperative Circulating Tumor DNA Monitoring for Colorectal

      Active, not recruiting
      • Colorectal Cancer
      • Serial ctDNA monitoring
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Nov 28, 2023

      Tumor Recurrence, Malignant Epithelial Tumor of Vulva, Malignant Epithelial Tumor of Ovary Trial in Pavia (carbon ion radiation

      Recruiting
      • Tumor Recurrence
      • +3 more
      • carbon ion radiation therapy
      • Pavia, Pv, Italy
        CNAO
      Jul 13, 2022

      s Recurrence and Response Via a Tumor Informed Assessment

      Recruiting
      • Cancer
      • +4 more
      • Personalized Cancer Monitoring (PCM)
      • San Francisco, California
      • +1 more
      Dec 5, 2022

      Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • +13 more
      • (no location specified)
      Aug 29, 2023

      Liver Cancer Trial in Nanning (Autotransfusion, Control group)

      Recruiting
      • Liver Cancer
      • Autotransfusion
      • Control group
      • Nanning, Guangxi, China
        Affiliated Tumor Hospital of Guangxi Medical University
      Jan 14, 2022

      Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

      Active, not recruiting
      • Melanoma
        • Murray, Utah
        • +1 more
        Feb 17, 2023

        Hepatocellular Carcinoma Recurrence After Curative Treatment by

        Recruiting
        • Hepatocellular Carcinoma Resectable
        • circulating tumor DNA
        • Foshan, Guangdong, China
        • +5 more
        Nov 27, 2023

        NSCLC Trial in Shanghai

        Not yet recruiting
        • Non-small Cell Lung Cancer
          • Shanghai, Shanghai, China
            Shanghai Pulmonary Hospital
          Jul 20, 2023

          NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy

          Recruiting
          • Glioblastoma
          • Tumor samples from patients treated with TTFields at initial diagnosis.
          • Tumor samples from patients treated with TTFields at tumor recurrence.
          • Milwaukee, Wisconsin
            Froedtert & the Medical College of Wisconsin
          Feb 9, 2022

          Mastectomy Trial in Seoul (reSLNB arm)

          Recruiting
          • Mastectomy
          • reSLNB arm
          • Seoul, Korea, Republic of
            Gangnam Severance Hospital, Yonsei University College of Medicin
          Jul 26, 2021

          Bladder Cancer, Epirubicin Adverse Reaction, Superficial Bladder Cancer Trial in Ankara (Intravesical Solution)

          Recruiting
          • Bladder Cancer
          • +3 more
          • Intravesical Solution
          • Ankara, Altindag, Turkey
            Ankara Training and Research Hospital
          Jul 4, 2022

          Hepatocellular Carcinoma Trial (circulating tumor DNA dosage)

          Not yet recruiting
          • Hepatocellular Carcinoma
          • circulating tumor DNA dosage
          • (no location specified)
          May 16, 2022

          Clinical Research of Drug Holiday Based on MRD Detection in GIST

          Recruiting
          • Gastrointestinal Stromal Tumors
            • Beijing, Beijing, China
              Peking University People's Hospital
            May 11, 2023

            Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

            Recruiting
            • Neuroblastoma
            • +2 more
            • Columbus, Ohio
              Nationwide Children's Hospital
            Dec 20, 2022

            Recurrence Score on Adjuvant Treatment Decisions in Breast

            Recruiting
            • Breast Cancer Female
              • Tübingen, BW, Germany
                Department for Women's Health
              Nov 4, 2022

              Thymic Epithelial Tumor Trial (HITOC)

              Recruiting
              • Thymic Epithelial Tumor
              • HITOC
              • Shanghai, China
                Shanghai Zhongshan Hospital
              Sep 15, 2022

              Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

              Completed
              • Pancreatic Neuroendocrine Tumor G2
              • Octreotide LAR
              • (no location specified)
              Oct 17, 2023

              Glioblastoma Trial in Münster (Gliolan, Radiodynamic therapy)

              Recruiting
              • Glioblastoma
              • Münster, Germany
                University Hospital Münster, Klinik für Neurochirurgie
              Nov 16, 2022